Abstract | BACKGROUND: OBJECTIVE: METHODS:
R1479 and balapiravir solutions were prepared at different pH values and stored at various temperatures. An ion pair high-performance liquid chromatography (HPLC) method with gradient elution was employed to analyze the prodrug, parent, and degradation products. Azide was measured using a reversed phase HPLC method with UV detection after formation of the 3,5-dinitrobenzoyl azide derivative with 3,5-dinitrobenzoyl chloride. The data were analyzed using initial rate and conventional first-order kinetic methods. RESULTS: CONCLUSION:
Azide release is pH dependent and is faster in acidic solutions than in neutral solutions. The amount of azide released is significantly less from balapiravir than that from R1479, suggesting a potential advantage of the prodrug over the parent drug.
|
Authors | Fujun Li, Xiaoyang Wu, Xu Hadig, Sujuan Huang, Lei Hong, Tony Tran, Michael Brandl, Tom Alfredson |
Journal | Drug development and industrial pharmacy
(Drug Dev Ind Pharm)
Vol. 36
Issue 4
Pg. 413-20
(Apr 2010)
ISSN: 1520-5762 [Electronic] England |
PMID | 19778160
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- Azides
- Nucleosides
- Prodrugs
- Cytidine
- 4'-azidocytidine
- balapiravir
|
Topics |
- Antiviral Agents
(chemistry)
- Azides
(chemistry)
- Chemical Phenomena
- Cytidine
(analogs & derivatives, chemistry)
- Drug Stability
- Hydrogen-Ion Concentration
- Nucleosides
(chemistry)
- Prodrugs
(chemistry)
|